Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01693731 · ClinicalTrials.gov registry record
Oral Health in Breast Cancer Survivors on Aromatase Inhibitors
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 300
- Enrollment target
NCT01693731 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 300 participants.
The verdict
NCT01693731 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how aromatase inhibitors (AIs) such as Arimidex, Aromasin or Femara affect a woman's oral health and oral health related quality of life. Patients, dental professionals and medical oncologists will benefit from a greater understanding of the best oral care follow up practices of breast cancer survivors using aromatase inhibitors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2012-04 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01693731
The ClinicalTrials.gov registry entry for NCT01693731 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01693731 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01693731 about?
NCT01693731 is a clinical study titled "Oral Health in Breast Cancer Survivors on Aromatase Inhibitors". The purpose of this study is to determine how aromatase inhibitors (AIs) such as Arimidex, Aromasin or Femara affect a woman's oral health and oral health related quality of life. Patients, dental professionals and medical oncologists will benefit from a greater understanding of the best oral care f...
What is the current status of trial NCT01693731?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2012-04. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT01693731?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.